As noted, IRE1 and PERK signaling are critical for RMS cell survival, with IRE1 inhibitor MKC8866 and PERK inhibitor AMGEN44 inducing senescence in rhabdomyosarcoma cells to curb proliferation. Here, ERN1 is linked to rhabdomyosarcoma.